Black lung persistent pulmonary hypertension of the newborn

References

1. ↵
   1. Jyothula S,
   2. Safdar Z

   (2009) Update on pulmonary hypertension complicating chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis 4:351–363.

   OpenUrlPubMed
2. ↵
   1. Walsh MC,
   2. Stork EK

   (2001) Persistent pulmonary hypertension of the newborn. Rational therapy based on pathophysiology. Clin Perinatol 28:609–627.

   OpenUrlCrossRefPubMedWeb of Science
3. ↵
   1. Makris A,
   2. Seferou M,
   3. Papadopoulos DP

   (2010) Resistant hypertension workup and approach to treatment. Int J Hypertens 2011:598694.

   OpenUrlPubMed
4. ↵
   1. Yeh TF

   (2001) Persistent pulmonary hypertension in preterm infants with respiratory distress syndrome. Pediatr Pulmonol 23:103–106.

   OpenUrl
5. ↵
   1. Chambers CD,
   2. Hernandez-Diaz S,
   3. Van Marter LJ,
   4. Werler MM,
   5. Louik C,
   6. Jones KL,
   7. et al.

   (2006) Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 354:579–587.

   OpenUrlCrossRefPubMedWeb of Science
6. ↵
   1. Evans N,
   2. Kluckow M,
   3. Currie A

   (1998) Range of echocardiographic findings in term neonates with high oxygen requirements. Arch Dis Child Fetal Neonatal Ed 78:F105–F111.

   OpenUrlAbstract/FREE Full Text
7. ↵
   1. Weijerman ME,
   2. van Furth AM,
   3. van der Mooren MD,
   4. van Weissenbruch MM,
   5. Rammeloo L,
   6. Broers CJ,
   7. et al.

   (2010) Prevalence of congenital heart defects and persistent pulmonary hypertension of the neonate with Down syndrome. Eur J Pediatr 169:1195–1199.

   OpenUrlCrossRefPubMed
8. ↵
   1. Cua CL,
   2. Blankenship A,
   3. North AL,
   4. Hayes J,
   5. Nelin LD

   (2007) Increased incidence of persistent pulmonary hypertension in Down syndrome neonates. Pediatr Cardiol 28:250–254.

   OpenUrlCrossRefPubMed
9. ↵
   1. Hernández-Díaz S,
   2. Van Marter LJ,
   3. Werler MM,
   4. Louik C,
   5. Mitchell AA

   (2007) Risk factors for persistent pulmonary hypertension of the newborn. Pediatrics 120:e272–e282.

   OpenUrlAbstract/FREE Full Text
10. ↵
    1. Herrera EA,
    2. Riquelme RA,
    3. Ebensperger G,
    4. Reyes RV,
    5. Ulloa CE,
    6. Cabello G,
    7. et al.

    (2010) Long-term exposure to high-altitude chronic hypoxia during gestation induces neonatal pulmonary hypertension at sea level. Am J Physiol Regul Integr Comp Physiol 299:R1676–R1684.

    OpenUrlCrossRefPubMedWeb of Science
11. ↵
    1. Niermeyer S,
    2. Andrade-M MP,
    3. Vargas E,
    4. Moore LG

    (2015) Neonatal oxygenation, pulmonary hypertension, and evolutionary adaptation to high altitude (2013 Grover Conference series). Pulm Circ 5:48–62.

    OpenUrlCrossRefPubMed
12. ↵
    1. Khorana M,
    2. Yookaseam T,
    3. Layangool T,
    4. Kanjanapattanakul W,
    5. Paradeevisut H

    (2011) Outcome of oral sildenafil therapy on persistent pulmonary hypertension of the newborn at Queen Sirikit National Institute of Child Health. J Med Assoc Thai 94(Suppl3):S64–S73.

    OpenUrlPubMed
13. ↵
    1. Yaseen H,
    2. Darwich M,
    3. Hamdy H

    (2012) Is sildenafil an effective therapy in the management of persistent pulmonary hypertension? J Clin Neonatol 1:171–175.

    OpenUrlCrossRefPubMed